Aggressive variant prostate cancer (AVPC) is characterized by a molecular signature involving combined defects in TP53, RB1, and/or PTEN (AVPC-TSGs), identifiable through immunohistochemistry or ...

Surgery remains the cornerstone of localized renal cell carcinoma (RCC) care. Pembrolizumab has recently been recommended as a standard of care for RCC patients who are at high risk of recurrence.

Magnetic resonance-guided transurethral ultrasound ablation (MR-TULSA) is a new focal therapy for treating localised prostate cancer that is associated with fewer adverse effects (AEs) compared with ...

The role of repeat transurethral resection of bladder tumor (TURBT) for the management of nonmuscle invasive bladder carcinoma is debated, especially when initial resections include detrusor muscle.

PSMA-PET is a reference standard examination for patients with prostate cancer, but even using recently introduced digital PET detectors image acquisition with standard field-of-view scanners is still ...

Patient-reported outcome measures (PROMs) are increasingly being used to capture the patients' perspective of their functional status and quality of life (QoL). Big data can help us better understand ...

Prostate cancer (PC) treatment remains a challenge, particularly in its advanced, castration-resistant form (CRPC), where resistance to androgen receptor (AR)-targeted therapies, such as enzalutamide ...

In the last couple of decades, we have witnessed an increase in the incidence of cancer worldwide, particularly in Western Europe and the United States. Fortunately, this trend is accompanied by ...

To evaluate outcomes of onco-testis sperm extraction (TESE) and to define potential predictors of successful surgical sperm retrieval (SSR). For this study, we examined all men (i) diagnosed with a ...

LITESPARK-005 evaluated belzutifan against everolimus in advanced renal cell carcinoma (RCC),1 demonstrating significant progression-free survival improvement but failing to meet the overall survival ...

Radical prostatectomy (RP) is a cornerstone treatment for localized prostate cancer (PCa), offering curative potential for patients with organ-confined disease. Despite advancements in surgical ...

Botulinum Toxin vs. Sling Surgery for Mixed Urinary Incontinence in Women - Heidi Harvie ...